ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Inari Medical, Inc. (NASDAQ: NARI) to Stryker for $80.00 per share in cash is fair to Inari shareholders.
The investigation concerns whether Inari and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Inari shareholders; (2) determine whether Stryker is underpaying for Inari; and (3) disclose all material information necessary for Inari shareholders to adequately assess and value the merger consideration.
On behalf of Inari shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
